 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Over the last three days, A.I.dvisor has detected that FENC's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...

Fennec Pharmaceuticals (FENC, $9.47) Aroon Indicator entered an Uptrend on December 08, 2023.

This is a signal that FENC's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...

Fennec Pharmaceuticals (FENC, $9.32) RSI Indicator left the overbought zone on December 07, 2023

Fennec Pharmaceuticals (FENC, $9.32) Aroon Indicator entered an Uptrend on December 07, 2023.

Fennec Pharmaceuticals (FENC, $9.03) Aroon Indicator entered an Uptrend on December 06, 2023.

Fennec Pharmaceuticals (FENC, $9.03) RSI Indicator left the overbought zone on December 06, 2023

Fennec Pharmaceuticals (FENC, $9.23) Aroon Indicator entered an Uptrend on December 05, 2023.

~ Supports Strategic Discussions and Global Launch Activities ~ ~ Extends Access to Additional Undrawn Capital As Needed During Global PEDMARK Rollout ~ ~ Facilitates Market Expansion...

Fennec Announces Incremental $5 Million Investment from Petrichor

Fennec Pharmaceuticals (FENC, $9.19) RSI Indicator left the overbought zone on December 04, 2023

This price move could be a signal that FENC may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...

Fennec Pharmaceuticals (FENC, $9.19) price may drop as it broke higher Bollinger Band on Dec 04, 2023

This is a signal that FENC's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...

Fennec Pharmaceuticals (FENC, $9.19) Stochastic Oscillator left the overbought zone on December 04, 2023

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients. The company was founded by Orest W. Blaschuk on September 3, 1996 and is headquartered in Durham, NC.

Market Cap	$252.23M
Volume (M)	8,839.00
52-Wk High	$10.85
52-Wk Low	$6.30

FENC Fennec Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals

Sentiment

Message Volume

Community